RECORD // Company

OnKure Therapeutics, Inc.

Formerly: Reneo Pharmaceuticals, Inc.

Built 2026-11-22T00:35:45Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)

2 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-04 · accession 0001193125-26-447202

ItemValuePeriodFormFiledAccessionReport
Net income (loss)$-17,846,0003 months ended 2026-09-3010-Q2026-11-040001193125-26-4472022026-11-22 00:35 UTCReport an error
Cash and cash equivalents$151,443,000at 2026-09-3010-Q2026-11-040001193125-26-4472022026-11-22 00:35 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Revenue, Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001637715
Ticker
OKUR
EIN
472309515
CUSIP
68277Q105
Record ID
sx:sec:0001637715

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

31 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-20SEC EDGAR company profile2026-11-22 00:35 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-20SEC EDGAR company profile2026-11-22 00:35 UTCReport an error
State of incorporationDE2026-11-20SEC EDGAR company profile2026-11-22 00:35 UTCReport an error
Fiscal year end (MMDD)12312026-11-20SEC EDGAR company profile2026-11-22 00:35 UTCReport an error
Business address6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 803012026-11-20SEC EDGAR company profile2026-11-22 00:35 UTCReport an error
ExchangesNasdaq2026-11-20SEC EDGAR company profile2026-11-22 00:35 UTCReport an error
Revenue (fiscal year ended 2024-12-31)$02024-12-3110-K, XBRL Revenues2026-11-22 00:35 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-59,517,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-22 00:35 UTCReport an error
Total assets (at 2025-12-31)$62,117,0002025-12-3110-K, XBRL Assets2026-11-22 00:35 UTCReport an error
Stockholders' equity (at 2025-12-31)$56,184,0002025-12-3110-K, XBRL StockholdersEquity2026-11-22 00:35 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$59,050,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 00:35 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-51,828,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 00:35 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$46,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 00:35 UTCReport an error
Operating lease liabilities (at 2025-12-31)$549,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 00:35 UTCReport an error
Form D total offering amount (D filed 2024-10-21)$65,000,0002024-10-21D2026-11-22 00:35 UTCReport an error
Form D total amount sold (D filed 2024-10-21)$65,000,0002024-10-21D2026-11-22 00:35 UTCReport an error
Form D industry groupPharmaceuticals2024-10-21D2026-11-22 00:35 UTCReport an error
Form D revenue rangeDecline to Disclose2024-10-21D2026-11-22 00:35 UTCReport an error
Form D date of first sale2024-10-042024-10-21D2026-11-22 00:35 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-04)On November 4, 2026, OnKure Therapeutics, Inc. issued a press release reporting financial results for the quarter ended September 30, 2026. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. All of the information furnished in this Item 2.02 and Item 9.01 (including Exhibit 99.1) of this report shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth…2026-11-04SEC EDGAR 8-K 0001193125-26-447247 (text as filed, excerpt)2026-11-22 00:35 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-08-04)On August 4, 2026, OnKure Therapeutics, Inc. issued a press release reporting financial results for the quarter ended June 30, 2026. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. All of the information furnished in this Item 2.02 and Item 9.01 (including Exhibit 99.1) of this report shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by…2026-08-04SEC EDGAR 8-K 0001193125-26-332809 (text as filed, excerpt)2026-11-22 00:35 UTCReport an error
Largest institutional holder #1 (13F as filed): RA CAPITAL MANAGEMENT, L.P.$18,232,3982026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:35 UTCReport an error
Largest institutional holder #2 (13F as filed): BVF INC/IL$14,755,1482026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:35 UTCReport an error
Largest institutional holder #3 (13F as filed): ACORN CAPITAL ADVISORS, LLC$12,948,9132026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:35 UTCReport an error
Largest institutional holder #4 (13F as filed): StepStone Group LP$12,132,3912026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:35 UTCReport an error
Largest institutional holder #5 (13F as filed): ADAR1 Capital Management, LLC$10,208,3992026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:35 UTCReport an error
Largest institutional holder #6 (13F as filed): Vivo Capital, LLC$8,790,3582026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:35 UTCReport an error
Largest institutional holder #7 (13F as filed): Vestal Point Capital, LP$8,325,1872026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:35 UTCReport an error
Largest institutional holder #8 (13F as filed): BlackRock, Inc.$6,839,2942026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:35 UTCReport an error
Largest institutional holder #9 (13F as filed): Trails Edge Capital Partners, LP$6,559,3592026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:35 UTCReport an error
Largest institutional holder #10 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$6,552,8982026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:35 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.